Journal List > Allergy Asthma Respir Dis > v.7(2) > 1126504

Lee, Kim, Kim, Kim, Kim, Kim, Kim, Kim, Park, Seo, Sol, Sung, Song, Song, Ahn, Lee, Jang, Chung, Chung, Choi, Choi, Han, Yang, Shim, Kim, Oh, Yu, Lee, Lee, and Jang: Seasonal patterns and etiologies of croup in children during the period 2010–2015: A multicenter retrospective study

Abstract

Purpose

Croup is known to have epidemics in seasonal and biennial trends, and to be strongly associated with epidemics of para-influenza virus. However, seasonal and annual epidemics of croup have not been clearly reported in Korea. This study aimed to examine the seasonal/annual patterns and etiologies of childhood croup in Korea during a consecutive 6-year period.

Methods

Pediatric croup data were collected from 23 centers in Korea from 1 January 2010 to 31 December 2015. Electronic medical records, including multiplex reverse transcription polymerase chain reaction (RT-PCR) results, demographics and clinical information were cross-sectionally reviewed and analyzed.

Results

Overall, 2,598 childhood croup patients requiring hospitalization were identified during the study period. Among them, a

Conclusion

It is concluded that croup hospitalization has a biennial pattern in even-numbered years. PIV may be the most common cause of childhood croup; however, croup epidemics could be attributed to other viruses.

References

1. Cherry JD. Clinical practice. Croup. N Engl J Med. 2008; 358:384–91.
2. Bjornson CL, Johnson DW. Croup. Lancet. 2008; 371:329–39.
crossref
3. Lee DR, Lee CH, Won YK, Suh DI, Roh EJ, Lee MH, et al. Clinical characteristics of children and adolescents with croup and epiglottitis who visited 146 Emergency Departments in Korea. Korean J Pediatr. 2015; 58:380–5.
crossref
4. McEniery J, Gillis J, Kilham H, Benjamin B. Review of intubation in severe laryngotracheobronchitis. Pediatrics. 1991; 87:847–53.
crossref
5. Denny FW, Murphy TF, Clyde WA Jr, Collier AM, Henderson FW. Croup: an 11-year study in a pediatric practice. Pediatrics. 1983; 71:871–6.
crossref
6. Segal AO, Crighton EJ, Moineddin R, Mamdani M, Upshur RE. Croup hospitalizations in Ontario: a 14-year time-series analysis. Pediatrics. 2005; 116:51–5.
crossref
7. Marx A, Török TJ, Holman RC, Clarke MJ, Anderson LJ. Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis. 1997; 176:1423–7.
crossref
8. Rosychuk RJ, Klassen TP, Voaklander DC, Senthilselvan A, Rowe BH. Seasonality patterns in croup presentations to emergency departments in Alberta, Canada: a time series analysis. Pediatr Emerg Care. 2011; 27:256–60.
9. Weinberg GA, Hall CB, Iwane MK, Poehling KA, Edwards KM, Griffin MR, et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr. 2009; 154:694–9.
crossref
10. Rihkanen H, Rönkkö E, Nieminen T, Komsi KL, Räty R, Saxen H, et al. Respiratory viruses in laryngeal croup of young children. J Pediatr. 2008; 152:661–5.
crossref
11. Wall SR, Wat D, Spiller OB, Gelder CM, Kotecha S, Doull IJ. The viral aetiology of croup and recurrent croup. Arch Dis Child. 2009; 94:359–60.
crossref
12. Kim EJ, Nam H, Sun YH, Tchah H, Ryoo E, Cho HK, et al. Comparison of etiology and clinical presentation between children with laryngotra-cheobronchopneumonitis and croup. Allergy Asthma Respir Dis. 2017; 5:274–9.
crossref
13. Jeon IS, Cho WJ, Lee J, Kim HM. Epidemiology and clinical severity of the hospitalized children with viral croup. Pediatr Infect Vaccine. 2018; 25:8–16.
crossref
14. Kim KH, Lee JH, Sun DS, Kim YB, Choi YJ, Park JS, et al. Detection and clinical manifestations of twelve respiratory viruses in hospitalized children with acute lower respiratory tract infections: Focus on human metapneumovirus, human rhinovirus and human coronavirus. Korean J Pediatr. 2008; 51:834–41.
15. Sung JY, Lee HJ, Eun BW, Kim SH, Lee SY, Lee JY, et al. Role of human coronavirus NL63 in hospitalized children with croup. Pediatr Infect Dis J. 2010; 29:822–6.
crossref
16. van der Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, et al. Croup is associated with the novel coronavirus NL63. PLoS Med. 2005; 2:e240.
crossref
17. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, et al. Identification of a new human coronavirus. Nat Med. 2004; 10:368–73.
crossref
18. Chiu SS, Chan KH, Chu KW, Kwan SW, Guan Y, Poon LL, et al. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis. 2005; 40:1721–9.
crossref
19. Han TH, Chung JY, Kim SW, Hwang ES. Human Coronavirus-NL63 infections in Korean children, 2004–2006. J Clin Virol. 2007; 38:27–31.
crossref
20. Wu PS, Chang LY, Berkhout B, van der Hoek L, Lu CY, Kao CL, et al. Clinical manifestations of human coronavirus NL63 infection in children in Taiwan. Eur J Pediatr. 2008; 167:75–80.
crossref
21. Zeng ZQ, Chen DH, Tan WP, Qiu SY, Xu D, Liang HX, et al. Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China. Eur J Clin Microbiol Infect Dis. 2018; 37:363–9.
crossref
22. Regamey N, Kaiser L, Roiha HL, Deffernez C, Kuehni CE, Latzin P, et al. Viral etiology of acute respiratory infections with cough in infancy: a community-based birth cohort study. Pediatr Infect Dis J. 2008; 27:100–5.
23. Camara AA, Silva JM, Ferriani VP, Tobias KR, Macedo IS, Padovani MA, et al. Risk factors for wheezing in a subtropical environment: role of respiratory viruses and allergen sensitization. J Allergy Clin Immunol. 2004; 113:551–7.
24. Manning A, Russell V, Eastick K, Leadbetter GH, Hallam N, Templeton K, et al. Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis. 2006; 194:1283–90.
crossref
25. Gagliardi TB, Iwamoto MA, Paula FE, Proença-Modena JL, Saranzo AM, Criado MF, et al. Human bocavirus respiratory infections in children. Epidemiol Infect. 2009; 137:1032–6.
crossref
26. Jartti T, Lehtinen P, Vuorinen T, Koskenvuo M, Ruuskanen O. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol. 2004; 72:695–9.
crossref
27. von Linstow ML, Høgh M, Høgh B. Clinical and epidemiologic characteristics of human bocavirus in Danish infants: results from a prospective birth cohort study. Pediatr Infect Dis J. 2008; 27:897–902.
28. Williams JV, Edwards KM, Weinberg GA, Griffin MR, Hall CB, Zhu Y, et al. Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis. 2010; 201:1890–8.
crossref
29. Everard ML. Acute bronchiolitis and croup. Pediatr Clin North Am. 2009; 56:119–33. x-xi.
crossref
30. Chapman RS, Henderson FW, Clyde WA Jr, Collier AM, Denny FW. The epidemiology of tracheobronchitis in pediatric practice. Am J Epidemiol. 1981; 114:786–97.
31. Waites KB, Atkinson TP. The role of Mycoplasma in upper respiratory infections. Curr Infect Dis Rep. 2009; 11:198–206.
crossref
32. Tyler A, McLeod L, Beaty B, Juarez-Colunga E, Birkholz M, Hyman D, et al. Variation in Inpatient Croup Management and Outcomes. Pediatrics. 2017; 139(4):pii: e20163582.
crossref
33. Syrmis MW, Whiley DM, Thomas M, Mackay IM, Williamson J, Siebert DJ, et al. A sensitive, specific, and cost-effective multiplex reverse tran-scriptase-PCR assay for the detection of seven common respiratory viruses in respiratory samples. J Mol Diagn. 2004; 6:125–31.
crossref

Fig. 1.
Pathogens detected in hospitalized children with croup between 2010 and 2015. A total of 927 children with croup were hospitalized between 1 January 2010 through 31 December 2015. Among them, most prevalent age group was <2 years old (n=584, 63.0%). Most commonly detected pathogen was parainfluenza virus under the age of 4 years. MP, Mycoplasma pneumoniae; AdV, adenovirus; RV, human rhinovirus; Flu, influenza virus; PIV, parainfluenza virus; HMPV, human metapneumovirus; RSV, respiratory syncytial virus; BoV, bocavirus; CoV, coronavirus.
aard-7-78f1.tif
Fig. 2.
Numbers of hospitalized children with croup and pathogen-detected croup between 1 January 2010 through 31 December 2015, according to month and year. A total of 2,598 hospitalized children with croup were identified. Among them respiratory pathogens were detected in 927 children.
aard-7-78f2.tif
Fig. 3.
Distribution of pathogen-detected croup between 1 January 2010 and 31 December 2015, according to month and year. (A) Pathogens detected in hospitalized children with croup. (B) Distribution of PIV, and PIV subtypes. (C) Distribution of CoV and CoV subtypes. AdV, adenovirus; HRV, human rhinovirus; Flu, influenza virus; PIV, parainfluenza virus; HMPV, human metapneumovirus; RSV, respiratory syncytial virus; BoV, bocavirus; HCoV, human coronavirus.
aard-7-78f3.tif
Table 1.
Characteristics among 927 hospitalized childhood croup from 1 January 2010 to 31 December 2015
Variable Value
Age (mo), median (IQR) 19 (11–31)
Age group (yr)  
<2 584 (63.0)
2–4 266 (28.7)
5–9 62 (6.7)
10–17 15 (1.6)
Male sex 570 (61.5)
Season at hospitalization  
Spring (March–May) 264 (28.5)
Summer (June–August) 253 (27.3)
Autumn (September–November) 247 (26.6)
Winter (December–February) 163 (17.6)
Hospitalization-related information  
Length of stay (hr), mean±SD 126.7±92.1
Intensive care unit admission 1 (0.1)
Oxygen supply 84 (9.1)
Use of corticosteroids 166 (17.9)
Oral prednisolone 44 (4.8)
Methylprednisolone 42 (4.5)
Dexamethasone 121 (13.1)

Values are presented number (%) unless otherwise indicated. IQR, interquartile range; SD, standard deviation.

Table 2.
Respiratory pathogens and laboratory findings among 927 hospitalized childhood croup from 1 January 2010 to 31 December 2015
Variable Value
Identified-pathogen 721 (77.8)
Single 521 (56.2)
Adenovirus 14 (2.7)
Human rhinovirus 65 (12.5)
Influenza virus 34 (6.5)
Parainfluenza virus 207 (39.7)
Human metapneumovirus 24 (4.61)
Respiratory syncytial virus 78 (15.0)
Bocavirus 6 (1.2)
Coronovirus 38 (7.3)
Mycoplama pneumoniae 55 (10.6)
Multiple 200 (21.6)
No identification 206 (22.2)
Laboratory findings  
WBC (×103/μL) 11.3±4.8
Neutrophil (%) 48.7±19.5
Lymphocyte (%) 38.9±17.6
Eosinophil (%) 1.4±2.1
Platelet count (×103/μL) 294.5±104.8
AST (U/L) 40.6±33.3
ALT (U/L) 22.5±45.9
LDH (U/L) 361.8±45.9
CRP (mg/dL) 3.2±6.9
ESR (mm/hr) 18.2±16.7

Values are presented as number (%) or mean±standard deviation.

Multiple, multiple pathogens with coinfection; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.

Table 3.
Comparison of clinical characteristics and laboratory findings among hospitalized children with croup due to single adenovirus, influenza virus, parainfluenza virus, respiratory syncytial virus, corona virus, and Mycoplasma pneumoniae infection
Variable 1. AdV (n=14) 2. Flu (n=34) 3. PIV (n=207) 4. RSV (n=78) 5. CoV (n=24) 6. MP (n=27) P-value Post hoc test
Age (mo), median (IQR) 24.5 (23.0) 26.0 (32.0) 17.0 (16.0) 16.0 (11.0) 13.0 (12.0) 66.0 (51.0) <0.01 5≤4=3≤1=2≤6
Male sex, n (%) 8 (57.1) 22 (64.7) 126 (60.9) 52 (66.7) 24 (63.2) 27 (49.1) 0.46  
LOS (hr), median (IQR) 120.0 (72.0) 120.0 (48.0) 96.0 (48.0) 120.0 (48.0) 96.0 (24.0) 144.0 (96.0) <0.01 3=5=4≤1=2≤6
ICU admission, n (%) 0 (0) 0 (0) 1 (0.5) 0 (0) 0 (0) 0 (0)    
Oxygen supply, n (%) 0 (0) 3 (8.8) 19 (9.2) 6 (7.7) 6 (15.8) 1 (1.8) 0.19  
Use of steroids, no. (%) 5 (35.7) 6 (17.7) 41 (19.8) 9 (11.5) 11 (29.0) 18 (32.7) 0.03  
Laboratory findings                
WBC (×103/μL), median (IQR) 10.47 (5.65) 8.77 (4.04) 9.80 (5.42) 10.97 (4.68) 12.99 (7.24) 7.89 (3.39) <0.01 6≤2≤3≤1≤4≤5
Neutrophil 48.5 (14.0) 58.0 (36.1) 46.0 (30.2) 45.5 (25.6) 49.8 (18.1) 56.6 (21.7) 0.12 4=3≤1=5≤6=2
Lymphocyte 32.7 (17.9) 32.0 (31.2) 40.7 (28.1) 40.3 (23.8) 36.3 (17.5) 30.4 (18.3) 0.03 6≤2=1=5=4≤3
Eosinophil 0.5 (1.4) 0.4 (0.8) 0.3 (0.8) 0.5 (1.4) 0.35 (1.3) 1.8 (3.0) <0.01 3=5=1=2=4<6
Platelet (×103/μL), median (IQR) 297.0 (81.0) 228.5 (60.0) 249.0 (104.0) 300.0 (108.5) 298.0 (90.0) 273.0 (118.0) <0.01 2=3≤6=1≤5=4
CRP (mg/dL), median (IQR) 2.05 (3.0) 0.83 (2.27) 0.96 (2.47) 1.08 (2.56) 1.06 (1.45) 1.50 (4.20) 0.37  
ESR (mm/hr), median (IQR) 33.0 (31.0) 7.0 (13.0) 10.0 (15.0) 11.0 (15.5) 7.0 (8.0) 26.0 (30.0) <0.01 2=5=3=4<6=1
AST (U/L), median (IQR) 30.0 (10.0) 39.5 (17.0) 37.0 (12.0) 39.0 (13.0) 37.0 (10.0) 31.0 (8.0) <0.01 1=6≤5=3=4=2
ALT (U/L), median (IQR) 15.5 (8.0) 15.0 (9.0) 16.0 (8.0) 17.0 (9.0) 19.5 (8.0) 12.0 (6.0) <0.01 6≤2=1=3=4=5
LDH (U/L), median (IQR) 270.0 (81.0) 286.0 (170.0) 327.0 (88.0) 324.0 (151.0) 516.0 (246.0) 436.0 (218.5) 0.24  

IQR, interquartile range; LOS, length of stay; AdV, adenovirus; Flu, influenza virus; PIV, parainfluenza virus; RSV, respiratory syncytial virus; CoV coronavirus; MP, Mycoplasma pneumoniae; ICU, intensive care unit; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase.

TOOLS
Similar articles